Full history for every metric is available with a Kvantra account
EMIS Group plc (EMIS.L)
Key financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 160 | 170 | 160 | 159 | 168 | 175 | 160 |
| Operating profit | £m | 28 | 27 | |||||
| Net profit | £m | 9 | 24 | 23 | 30 | 29 | 33 | 23 |
| EPS reported | £ | 0.52 | 0.36 | |||||
| Operating cashflow per share | £ | 0.73 | 0.73 | |||||
| Capex per share | £ | 0.11 | 0.11 | |||||
| FCF per share | £ | 0.62 | 0.62 | |||||
| Free cash flow | £m | 39 | 32 | |||||
| Net debt | £m | -42 | -48 | |||||
| Book value equity | £m | 142 | 132 | |||||
| Book value per share | £ | 2.23 | 2.09 | |||||
| Number of shares | m | 63.97 | 63.26 | |||||
| DPS (TTM paid) | £ | 0.39 | 0.39 |
Financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 36.00 | - | |||||
| P/B LTM | x | 8.29 | 9.31 | |||||
| P/S LTM | x | 6.74 | 7.73 | |||||
| P/FCF LTM | x | 30.22 | 38.08 | |||||
| EV/EBITDA LTM | x | 19.86 | 23.23 | |||||
| EV/Sales LTM | x | 6.50 | 7.43 | |||||
| Earnings Yield LTM | % | 2.78% | 2.73% | |||||
| FCF Yield | % | 3.31% | 2.63% | |||||
| Quality | ||||||||
| ROE | % | 23.28% | 24.48% | |||||
| ROIC | % | 15.27% | 15.27% | |||||
| Operating margin | % | 15.82% | 15.82% | |||||
| Gross margin | % | 92.64% | 92.64% | |||||
| FCF/Sales | % | 22.30% | 22.30% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +13.04% | -2.70% | |||||
| Sales Growth YoY | % | +4.25% | -6.21% | |||||
| Net Income Growth YoY | % | +14.08% | -4.64% | |||||
| FCF Growth | % | +8.30% | +4.25% | |||||
| Operating Profit Growth | % | -22.46% | -6.66% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 1.88% | 2.01% | |||||
| Dividend Growth | % | +9.94% | - | |||||
| Payout Ratio | % | 66.91% | 66.91% | |||||
| FCF/Debt | x | 8.96 | 8.25 | |||||
| Net Debt/EBITDA | x | -0.72 | -0.72 | |||||
| EBIT/Net interest | x | 52.25 | 52.25 | |||||
| Net debt/market cap | % | -3.52% | -3.93% | |||||
| Net debt/Equity | x | -0.29 | -0.37 | |||||
| Gross debt/equity | x | 0.03 | 0.03 | |||||
Company overview
EMIS Group plc, through its various subsidiaries, delivers integrated software solutions and digital systems tailored for healthcare professionals across the United Kingdom. The company's operations are segmented into EMIS Health and EMIS Enterprise. EMIS Health is dedicated to providing comprehensive technology for integrated care within the National Health Service, addressing primary care, community services, acute hospitals, and social care. Conversely, EMIS Enterprise targets the business-to-business (B2B) healthcare technology market, offering solutions for areas such as medication management, strategic partnerships, life sciences, and patient-centric digital services. Under its EMIS brand, the company supplies clinical software to numerous healthcare organizations. Its Patient brand focuses on delivering medical and wellbeing information directly to patients, alongside innovative "digital front door" services. Additionally, EMIS provides GP appraisal and training services. Community pharmacies benefit from their Pinnacle brand, which offers specialized service management solutions, while business intelligence tools are supplied to GP practices, federations, and commissioners. EMIS also operates Patient.info, an online health platform that provides personalized patient services and extensive medical content. Their Patient Access and EMIS Web platforms enable patients to conveniently order repeat prescriptions online and track their delivery. For pharmacies, the ProScript and ProScript Connect systems streamline the entire dispensing process, including tasks like labeling, endorsing, managing patient records, ordering supplies, and inventory control. Beyond these clinical applications, EMIS extends its offerings to include non-clinical ICT solutions for healthcare professionals and a broader range of public and private sector organizations, further complemented by essential ICT infrastructure and hosting services. Founded in 1987, EMIS Group plc maintains its headquarters in Leeds, United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
EMIS Group plc (EMIS.L)
EMIS Group plc, through its various subsidiaries, delivers integrated software solutions and digital systems tailored for healthcare professionals across the United Kingdom. The company's operations are segmented into EMIS Health and EMIS Enterprise. EMIS Health is dedicated to providing comprehensive technology for integrated care within the National Health Service, addressing primary care, community services, acute hospitals, and social care. Conversely, EMIS Enterprise targets the business-to-business (B2B) healthcare technology market, offering solutions for areas such as medication management, strategic partnerships, life sciences, and patient-centric digital services. Under its EMIS brand, the company supplies clinical software to numerous healthcare organizations. Its Patient brand focuses on delivering medical and wellbeing information directly to patients, alongside innovative "digital front door" services. Additionally, EMIS provides GP appraisal and training services. Community pharmacies benefit from their Pinnacle brand, which offers specialized service management solutions, while business intelligence tools are supplied to GP practices, federations, and commissioners. EMIS also operates Patient.info, an online health platform that provides personalized patient services and extensive medical content. Their Patient Access and EMIS Web platforms enable patients to conveniently order repeat prescriptions online and track their delivery. For pharmacies, the ProScript and ProScript Connect systems streamline the entire dispensing process, including tasks like labeling, endorsing, managing patient records, ordering supplies, and inventory control. Beyond these clinical applications, EMIS extends its offerings to include non-clinical ICT solutions for healthcare professionals and a broader range of public and private sector organizations, further complemented by essential ICT infrastructure and hosting services. Founded in 1987, EMIS Group plc maintains its headquarters in Leeds, United Kingdom.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free